The development of a point-of-care rapid test for Covid-19 in just months is a tribute to the creativity of the U.S. biotechnology sector and the power of free enterprise.
The development of a point-of-care rapid test for Covid-19 in just months is a tribute to the creativity of the U.S. biotechnology sector and the power of free enterprise.